Healthcare provider profile · identity verified

Penny Marie Morrison

Nurse Practitioner · ROANOKE, VA · NPI 1083357099

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	603	118
Levothyroxine Sodium	Levothyroxine Sodium	506	68
Gabapentin	Gabapentin	411	92
Potassium Chloride	Potassium Chloride	333	69
Trazodone Hcl	Trazodone Hcl	317	70
Eliquis	Apixaban	300	50
Amlodipine Besylate	Amlodipine Besylate	283	56
Atorvastatin Calcium	Atorvastatin Calcium	267	63
Famotidine	Famotidine	230	64
Donepezil Hcl	Donepezil Hcl	222	43
Escitalopram Oxalate	Escitalopram Oxalate	220	43
Lisinopril	Lisinopril	212	45
Lorazepam	Lorazepam	192	62
Mirtazapine	Mirtazapine	191	50
Buspirone Hcl	Buspirone Hcl	185	36
Sertraline Hcl	Sertraline Hcl	184	40
Memantine Hcl	Memantine Hcl	164	35
Rivastigmine	Rivastigmine Tartrate	162	40
Metoprolol Succinate	Metoprolol Succinate	152	30
Losartan Potassium	Losartan Potassium	147	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	146	27
Metformin Hcl	Metformin Hcl	133	28
Tamsulosin Hcl	Tamsulosin Hcl	131	27
Ondansetron Hcl	Ondansetron Hcl	127	56
Carvedilol	Carvedilol	116	27
Omeprazole	Omeprazole	108	25
Jardiance	Empagliflozin	104	14
Tramadol Hcl	Tramadol Hcl	103	34
Quetiapine Fumarate	Quetiapine Fumarate	102	25
Oxycodone Hcl	Oxycodone Hcl	97	38
Pantoprazole Sodium	Pantoprazole Sodium	95	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	93	38
Metoprolol Tartrate	Metoprolol Tartrate	93	30
Ibuprofen	Ibuprofen	91	26
Ciprofloxacin Hcl	Ciprofloxacin Hcl	88	49
Hydralazine Hcl	Hydralazine Hcl	88	21
Clopidogrel	Clopidogrel Bisulfate	81	18
Pregabalin	Pregabalin	78	19
Cephalexin	Cephalexin	68	52
Clonazepam	Clonazepam	68	18
Methenamine Hippurate	Methenamine Hippurate	68	14
Prednisone	Prednisone	67	34
Latanoprost	Latanoprost	63	15
Bumetanide	Bumetanide	62	13
Allopurinol	Allopurinol	60	11
Cefdinir	Cefdinir	60	50
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	59	28
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	57	15
Lactulose	Lactulose	57	18
Xarelto	Rivaroxaban	57	suppressed
Finasteride	Finasteride	55	11
Divalproex Sodium	Divalproex Sodium	54	15
Metformin Hcl Er	Metformin Hcl	53	suppressed
Levetiracetam	Levetiracetam	52	11
Oxybutynin Chloride	Oxybutynin Chloride	51	suppressed
Fluticasone Propionate	Fluticasone Propionate	49	16
Meloxicam	Meloxicam	49	14
Risperidone	Risperidone	49	14
Nystatin	Nystatin	48	28
Citalopram Hbr	Citalopram Hydrobromide	45	suppressed
Alprazolam	Alprazolam	44	11
Duloxetine Hcl	Duloxetine Hcl	44	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	44	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	42	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Bupropion Xl	Bupropion Hcl	41	suppressed
Lacosamide	Lacosamide	41	suppressed
Loperamide	Loperamide Hcl	41	27
Spironolactone	Spironolactone	41	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Diazepam	Diazepam	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Metolazone	Metolazone	36	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	31
Lamotrigine	Lamotrigine	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	35	16
Olanzapine	Olanzapine	34	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	33	19
Erythromycin	Erythromycin Base	33	18
Rosuvastatin Calcium	Rosuvastatin Calcium	33	suppressed
Amiodarone Hcl	Amiodarone Hcl	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	11
Meclizine Hcl	Meclizine Hcl	31	suppressed
Nystop	Nystatin	31	15
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Estradiol	Estradiol	29	suppressed
Ingrezza	Valbenazine Tosylate	28	suppressed
Sucralfate	Sucralfate	28	suppressed
Aripiprazole	Aripiprazole	27	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	27	suppressed
Novolog Flexpen	Insulin Aspart	27	11
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Simvastatin	Simvastatin	27	11
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	26	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	26	suppressed
Atenolol	Atenolol	25	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Midodrine Hcl	Midodrine Hcl	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Olanzapine Odt	Olanzapine	23	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	21
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Insulin Lispro	Insulin Lispro	21	suppressed
Methotrexate	Methotrexate Sodium	21	suppressed
Nebivolol Hcl	Nebivolol Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Fentanyl	Fentanyl	20	suppressed
Glipizide	Glipizide	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Ramelteon	Ramelteon	19	suppressed
Single Use Swab	Alcohol Antiseptic Pads	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Fluconazole	Fluconazole	18	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Topiramate	Topiramate	16	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	15	suppressed
Methimazole	Methimazole	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Baclofen	Baclofen	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Xifaxan	Rifaximin	14	suppressed
Azithromycin	Azithromycin	13	12
Carbamazepine Er	Carbamazepine	13	suppressed
Ceftriaxone	Ceftriaxone Sodium	13	12
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Indapamide	Indapamide	13	suppressed
Rexulti	Brexpiprazole	13	suppressed
Amoxicillin	Amoxicillin	12	11
Carbamazepine	Carbamazepine	12	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	12	suppressed
Ethambutol Hcl	Ethambutol Hcl	12	suppressed
Lidocaine Hcl	Lidocaine Hcl	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Pentasa	Mesalamine	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Sulfasalazine	Sulfasalazine	12	suppressed
Armour Thyroid	Thyroid,pork	11	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Gemtesa	Vibegron	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Klayesta	Nystatin	11	suppressed
Levofloxacin	Levofloxacin	11	11
Metronidazole	Metronidazole	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed
Simbrinza	Brinzolamide/Brimonidine Tart	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error